Published in Breast Cancer Res on February 21, 2017
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res (2000) 9.30
Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (2009) 9.00
Fallibility in estimating direct effects. Int J Epidemiol (2002) 8.34
Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res (2005) 6.49
Intra-individual change over time in DNA methylation with familial clustering. JAMA (2008) 6.17
Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet (2012) 4.04
CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res (1999) 3.66
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res (2010) 3.04
DNA methylation and breast carcinogenesis. Oncogene (2002) 3.03
Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst (2012) 2.77
Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res (2000) 2.73
The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat (2002) 2.71
Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Cancer Res (2004) 2.34
Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst (2011) 1.97
Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res (2001) 1.95
Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol (2003) 1.79
Reduction of the plasma concentration of C-reactive protein following nine months of endurance training. Int J Sports Med (2000) 1.60
Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. Cancer Res (1999) 1.58
CpG island methylation pattern in different human tissues and its correlation with gene expression. Biochem Biophys Res Commun (2009) 1.58
DNA hypermethylation in breast cancer and its association with clinicopathological features. Cancer Lett (2005) 1.48
Data-based approach for developing a physical activity frequency questionnaire. Am J Epidemiol (1998) 1.45
Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients. Breast Cancer Res Treat (2011) 1.22
Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health (2004) 1.21
DNA methylation in peripheral blood measured by LUMA is associated with breast cancer in a population-based study. FASEB J (2012) 1.21
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer (2001) 1.21
Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta Oncol (2015) 1.20
Epigenetics: differential DNA methylation in mammalian somatic tissues. FEBS J (2008) 1.18
BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2008) 1.16
Differential methylation of cell-free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis. Cancer (2010) 1.14
Possible mechanisms mediating an association between physical activity and breast cancer. Cancer (1998) 1.13
HIN-1, an inhibitor of cell growth, invasion, and AKT activation. Cancer Res (2005) 1.13
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. Breast Cancer Res Treat (2012) 1.09
Epigenome-wide Association Studies and the Interpretation of Disease -Omics. PLoS Genet (2016) 1.05
Fat or fit: the joint effects of physical activity, weight gain, and body size on breast cancer risk. Cancer (2012) 1.02
Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats. Carcinogenesis (2009) 0.98
The cell cycle and development: redundant roles of cell cycle regulators. Curr Opin Cell Biol (1999) 0.98
Influence of prediagnostic recreational physical activity on survival from breast cancer. Eur J Cancer Prev (2012) 0.97
The role of physical activity in breast cancer etiology. Semin Oncol (2010) 0.97
Gene promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat (2009) 0.97
Aberrant methylation of the cyclin D2 promoter in primary small cell, nonsmall cell lung and breast cancers. Int J Cancer (2003) 0.93
Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. Cancer Res (2003) 0.91
DNA methylation changes in a human cell model of breast cancer progression. Mutat Res (2010) 0.91
Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study. Breast Cancer Res Treat (2014) 0.88
Recreational and household physical activity at different time points and DNA global methylation. Eur J Cancer (2013) 0.88
Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy. Cancer Cell Int (2016) 0.87
Expanding epigenomics to archived FFPE tissues: an evaluation of DNA repair methodologies. Cancer Epidemiol Biomarkers Prev (2014) 0.87
The influence of one-carbon metabolism on gene promoter methylation in a population-based breast cancer study. Epigenetics (2011) 0.84
The multiple promoter methylation profile of PR gene and ERalpha gene in tumor cell lines. Life Sci (2003) 0.84
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. Int J Cancer (2015) 0.84
Dietary intake of fish, polyunsaturated fatty acids, and survival after breast cancer: A population-based follow-up study on Long Island, New York. Cancer (2015) 0.80
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Res Treat (2016) 0.77
Gene-Specific Promoter Methylation Status in Hormone-Receptor-Positive Breast Cancer Associates with Postmenopausal Body Size and Recreational Physical Activity. Int J Cancer Clin Res (2015) 0.77
DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Res Treat (2016) 0.77
Interaction between polyunsaturated fatty acids and genetic variants in relation to breast cancer incidence. J Cancer Epidemiol Prev (iMedPub) (2016) 0.75